PALO ALTO, CA / ACCESSWIRE / June 5, 2024 / Bioz, Inc., an innovative AI software company based in Silicon…
The new proprietary cell line development platform combines a robust cell line, transposon technology with high throughput clone screening and…
Thought Leaders Barbara Nosal, PhD, LMFT, LADC, and Don Grant, PhD, MA, MFA, DAC, SUDCC IV, to Address the Impact…
SAN DIEGO, June 4, 2024 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies,…
PALO ALTO, Calif., June 4, 2024 /PRNewswire/ -- DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new…
NESS ZIONA, Israel, and HAUT-MAUCO, France, June 4, 2024 /PRNewswire/ -- NRGene (TASE: NRGN), a leading international genomics AI company, and…
Masdar City to showcase why they are the leading destination for the life sciences sector at BIO24 ABU DHABI, UAE,…
HOUSTON, June 04, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its…
PARSIPPANY, NJ, June 04, 2024 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences® (OTCQX: IDXG), is proud to…
At a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced…